INTRODUCTION Background and Importance
The evidence in support of discharging home select emergency department (ED) patients with acute pulmonary embolism is continuing to accumulate. 1, 2 When compared head-to-head with inpatient care in randomized trials, outpatient management of ED patients who were objectively categorized as being at low risk for adverse outcomes has been shown to be noninferior on measures of efficacy and safety. 3, 4 Major specialty societies endorse the practice of avoiding unnecessary hospitalization for appropriately selected patients with pulmonary embolism. 5, 6 Hospitalization of patients who are candidates for ambulatory management exposes them to risks of hospital-acquired infection and Yet outpatient management is uncommonly used, with several notable exceptions. [11] [12] [13] [14] [15] Among 18,707 patients with acute objectively confirmed pulmonary embolism from 177 hospitals across 21 countries in the Registro Informatizado de la Enfermedad TromboEmbolica (RIETE) registry through 2014, only 909 (4.9%) were discharged home within 24 hours of ED arrival. 16 Site-ofcare management for patients with acute pulmonary embolism in the United States conforms to these global patterns. Studies from centers providing unscripted care, that is, without real-time clinical decision support or explicit clinical care pathways, show home discharge ranging from 1% to 8%. [17] [18] [19] These studies begin to characterize the population of patients in the United States who are selected for home discharge, but lack important details of their patients' clinical profiles (eg, vital signs, thrombus burden, prognostic pulmonary embolism risk scores) and outcomes (eg, number and reason of early return visits, complete 30-day outcome measures) necessary to characterize the contemporary practice patterns of emergency physicians in the United States. These real-life patient-level and outcomes data are important in understanding the management of patients in routine clinical practice, especially because a quarter of patients with venous thromboembolism have at least one exclusion criterion preventing their recruitment into randomized clinical trials and have higher adverse outcomes than their trial-eligible counterparts. 20 
Goals of This Investigation
We undertook this retrospective cohort study within 21 EDs in an integrated health care delivery system to evaluate the real-world practice patterns of United States emergency physicians in the disposition of ED patients with acute pulmonary embolism. We also sought to describe the characteristics of patients managed as outpatients and their clinical outcomes, determined a priori, which included 5-day returns for pulmonary embolism-related signs, symptoms, or interventions and 30-day major adverse events (major hemorrhage, recurrent venous thromboembolism, and all-cause mortality). We hypothesized that home discharge would be uncommon, would vary significantly between EDs, and would be safe and effective as judged by its 5-and 30-day outcomes. If these hypotheses are confirmed, this study may suggest that treating physicians know how to identify some patients with acute pulmonary embolism who are appropriate candidates for outpatient care. However, it would also raise the question of whether the pool of patients who can safely forgo the risks and costs of hospitalization could be expanded.
MATERIALS AND METHODS Study Design and Setting
This retrospective cohort study was conducted in 21 community medical centers across Kaiser Permanente Northern California, a large integrated health care delivery system that provides comprehensive medical care for more than 4 million members with approximately 1.2 million ED visits per year. 21 Kaiser Permanente members include approximately 33% of the population in areas served and are highly representative of the surrounding and statewide population. 22, 23 Kaiser Permanente Northern California fully implemented a comprehensive integrated electronic health record in 2009 (Epic, Verona, WI). 24 The study was approved by the Kaiser Permanente Northern California's institutional review board. Waiver of informed consent was obtained because of the observational nature of the study.
Emergency care was provided by emergency medicine residency-trained and board-certified (or board-prepared) physicians. In 2014, median ED census was 46,538 (interquartile range [IQR] 35,689 to 56,460) ( Table 1) . No departmental policies or clinical pathways were in place at the participating EDs during the study period to govern the management of patients with acute pulmonary embolism. Patient care was left to the discretion of the treating emergency physicians. All facilities had around-theclock access to computed tomography (CT) pulmonary angiography with timely interpretation by board-certified radiologists. Formal compression ultrasonography and ventilation perfusion imaging were unavailable for some duration each night. For example, most facilities had no nuclear medicine technician either in house or on call after 9 PM (the time varied by facility). Several facilities, however, had a technician available to come in after hours for select high-risk patients with suspected pulmonary embolism.
Patients who received a diagnosis of acute pulmonary embolism in the outpatient clinic setting were customarily referred to the ED for definitive care. All EDs provided predischarge patient education in regard to the disease and its treatment and had pharmacy available around the clock for discharge medications and supplemental patient education. Physicians discharging patients home with pulmonary embolism from the ED commonly used a standard computerized discharge order set for venous thromboembolism, which at the time recommended warfarin with concomitant bridging therapy using enoxaparin for most patients. Direct, or "novel," oral anticoagulants were rarely prescribed during the study period. Outpatient warfarin dosing was managed by each facility's pharmacy-led telephone-based oral anticoagulation service. The percentage of time in therapeutic range for the international normalized ratio during the study period varied by facility and ranged from 69% to 74%, calculated with the Rosendaal linear interpolation method. 25 Greater than 90% of patients with pulmonary embolism who were discharged home directly from the ED received follow-up with the anticoagulation service within 3 days and followup with their primary care provider within 7 days. † MAPLE was a 28-month study, but only 20 months of data from 14 facilities were included in this outpatient substudy because during the last 8 MAPLE months these EDs were participating in a prospective interventional study of an electronic clinical decision support tool designed to facilitate identification of ED patients with acute PE who were eligible for outpatient care, the eSPEED study.
31 ‡ Admissions do not include outpatient short-term observation unit admissions. § Major teaching status is defined as hospitals with a ratio of interns and residents to beds greater than or equal to 0.25. Minor teaching status is accorded hospitals with a ratio greater than 0 but less than 0.25. Hospitals with a ratio of 0 are classified as nonteaching. This formula is established under Medicare statute.
Selection of Participants
This outpatient substudy was part of a larger retrospective cohort study, the Management of Acute Pulmonary Embolism (MAPLE) study, described in full elsewhere. 27 The MAPLE cohort consisted of patients who were aged 18 years or older with at least one eligible ED visit throughout the study period. We electronically identified potentially eligible cases with International Classification of Diseases, Ninth Revision codes and then manually reviewed the electronic health records of the study candidates for objectively confirmed or presumed pulmonary embolism. 27 Diagnostic confirmation was based on a new contrast-filling defect on CT pulmonary angiography, a new high-probability ventilation-perfusion lung scan, or compression ultrasonography positive for proximal deep venous thrombosis in a patient with symptoms of acute pulmonary embolism. This last group was considered to have presumed pulmonary embolism and is commonly included in pulmonary embolism study cohorts. 3, 12, 17, 28, 29 Radiographic diagnosis was based on the final interpretation by a boardcertified diagnostic or nuclear radiologist, as indicated.
The Figure depicts the cohort assembly. Because this study sought to describe unscripted care, we excluded all cases of pulmonary embolism from 14 medical centers during their participation in an 8-month prospective interventional study of an electronic clinical decision support application to facilitate identification of patients who were eligible for outpatient care (the Electronic Support for PE Emergency Disposition [eSPEED] study). 30, 31 We also excluded patients who died in the ED and those who were discharged directly to a skilled nursing facility because they were neither hospitalized nor discharged to outpatient care.
Data Collection and Processing
The 13 abstractors were all practicing emergency physicians who received standardized training on data collection methods and use of the electronic data collection instrument, which was modified to its final form after pilot testing. The pilot was a 4-month iterative process that included 250 cases, undertaken by 3 abstractors and our programmer-analyst, building on knowledge accrued during our previous retrospective pulmonary embolism research. 32, 33 The principal investigator answered and arbitrated all coding questions and monitored data collection activities by reviewing each abstractor's performance at 10 regular intervals through the abstraction period.
Our retrospective calculation of the Pulmonary Embolism Severity Index score at ED disposition followed a 2-step process described elsewhere. 33 The performance of the index as a predictor of 30-day all-cause mortality has been validated in our practice setting. 27 The 11 weighted variables of the index and their definitions are reported in Table E1 , available online at http://www.annemergmed.com.
The most proximal location of embolism on CT pulmonary angiography was determined by a board-certified study radiologist reading the narrative of the official radiology report. 34 These locations were classified in the standard fashion. 35 A board-certified nuclear radiologist read the official interpretation of the ventilation-perfusion scans and reviewed the images when available to categorize the mismatch perfusion defect, using 3 sizes: greater than 49%, 26% to 49%, and 1% to 25%. 35 Both radiologist readers were blinded to the patients' clinical data.
We noted documentation in the electronic health record of consultations with hospitalists, pulmonologists, or hematologists for home-going patients and the degree of consultant involvement.
Facility-level variables included annual ED census, hospital bed capacity, overall hospitalization, Level I or II trauma center designation, teaching status (minor or major, as defined by the Medicare inpatient prospective payment system), the presence of residents rotating through the ED, and the presence of an outpatient short-term (<24-hour) observation unit or clinical decision area associated with the ED.
Outpatient management was defined as discharging patients home directly from the ED. Discharge to a skilled nursing facility was not considered outpatient management. Patients admitted to an outpatient shortterm (<24-hour) observation unit or clinical decision area were categorized with the inpatient group.
Five-day returns to the ED or inpatient units for pulmonary embolism-related signs, symptoms, or interventions included the following variables, defined a priori: complaints of dyspnea, chest pain, syncope or presyncope, limb pain or swelling, or bleeding; or findings of pleural effusion, elevated liver enzyme levels, new anemia or hemorrhage, or new or worsening deep venous thrombosis or pulmonary embolism; or interventions including assistance with medication administration, respiratory support (nonrebreather mask, noninvasive ventilation, intubation, or mechanical ventilation), parenteral vasopressor administration, inferior vena cava filter placement or removal, or cardiopulmonary resuscitation. The 5-day timeframe was selected a priori because it represents both a typical hospital length of stay for patients with acute pulmonary embolism in the United States and a temporal horizon of concern to emergency physicians for patients with pulmonary embolism. 36, 37 Thirty-day outcomes were defined a priori and included major hemorrhage, recurrent venous thromboembolism, and all-cause mortality. 1, 3, 32 Major hemorrhage was defined by the International Society on Thrombosis and Haemostasis as bleeding at high-risk anatomic locations (intracranial, intraspinal, intraocular, retroperitoneal, intraarticular, pericardial, or intramuscular with compartment syndrome), or overt bleeding with either a reduction of hemoglobin level greater than or equal to 2 g/dL or a transfusion of 2 or more units of RBCs. 38 Recurrent venous thromboembolism was defined as a new or expanded abnormality on imaging. Deaths were identified with a health system mortality database that links to the Social Security death master file and the California State Department of Vital Statistics to identify deaths both within and outside of the health care delivery system. For both 5-and 30-day outcomes, we also identified out-ofsystem medical encounters, using a comprehensive claims database to improve capture of all health care visits related to our post-ED outcomes.
A second reviewer abstracted specified variables on a randomly selected subset of 90 cases from the larger MAPLE study of 2,996 patients to measure interrater reliability. We report here only the 68 cases that were included in this study cohort of 2,387 cases. Variables included the 9 nondemographic variables of the Pulmonary Embolism Severity Index (Table E1 , available online at http://www.annemergmed.com), the Pulmonary Embolism Severity Index risk category (low [classes I to II] versus higher [classes III to V]), 5-day pulmonary embolism-related return visits, and major adverse events (described above).
Primary Data Analysis
Continuous variables are presented as medians with IQRs and categorical data are presented as frequencies and proportions. We examined the association between home discharge and patient characteristics that from the literature and our previous experience are considered relative or absolute contraindications to outpatient care or are known predictors of adverse events. 1, 32 For hypothesis generation, we used multivariable logistic regression with facility-level random effect to examine adjusted associations between patient characteristics and home discharge, including all variables with a moderate plausibility of difference between the 2 site-of-care groups (home versus admission) on bivariate analysis (P<.20). We used the variance inflation factor to check for multicollinearity. We did not include interaction terms in the regression model. The Pulmonary Embolism Severity Index was not included in the model because many of the component variables of the index were already included. We also performed a sensitivity analysis, calculating the primary outcome (direct home discharge) for an expanded cohort that included patients who were otherwise study eligible except for lacking 30 days of sustained health-plan membership. We reported the interrater reliability with a kappa/weighted kappa statistic, as well as percentage agreement. All analyses were conducted with SAS (version 9.31; SAS Institute, Inc., Cary, NC) and Stata (version 14.2; StataCorp, College Station, TX).
RESULTS
From the 28-month study period, 3,813 patients were electronically identified for screening and 600 of these (15.7%) were manually excluded (Figure) . Of the remaining 3,213 patients, 217 (6.8%) non-health plan members were excluded for incomplete 30-day outcome data. Of the remaining 2,996 patients, we excluded 604 because of participation in the eSPEED study (described above) and 5 because they were neither admitted to the hospital nor discharged home from the ED. The remaining 2,387 patients constitute our cohort (Figure) . This includes 2,349 individual patients, 38 of whom were enrolled on 2 separate occasions.
Diagnosis of pulmonary embolism was confirmed by CT pulmonary angiography in 2,180 patients (91.3%), by ventilation-perfusion scan in 127 (5.3%), and by compression ultrasonography with associated pulmonary embolism symptoms in 80 (3.3%), the latter percentage comparable with that of registry and trial studies.
3,17 Two hundred seventy-seven patients (11.6%) arrived in the ED with a recent positive outpatient pulmonary imaging study result. Clot localization and thrombus burden for patients undergoing pulmonary imaging are reported in Tables E2  and E3 , available online at http://www.annemergmed.com.
The median percentage of home discharge was 7.0% (IQR 4.2% to 10.9%), which varied significantly between EDs, ranging from 0% to 14.3%. Facility-specific variables are presented in Table 1 , none of which was associated with home discharge on bivariate analysis.
Overall, 179 patients (7.5%) were discharged home from the ED, a proportion that was stable across the duration of the study. 31 The percentage of home discharge was unchanged on sensitivity analysis when the cohort was expanded by the addition of 174 patients who were excluded only for lacking 30 days of sustained health-plan membership. Among the 2,208 hospitalized patients, 289 (13.1%) were admitted from the ED to a short-term (<24-hour) outpatient observation unit and 198 of these (68.5%) were discharged home from the unit. Tables 2 and 3 report patient characteristics, stratified by the site-of-care outcome. Variables associated with outpatient care in multivariable analysis are reported in Table E4 , available online at http://www. annemergmed.com. The variance inflation factor ranged from 1.02 to 2.05.
ED median length of stay was shorter for patients directly discharged home (5.4 hours; IQR 3.8 to 6.8 hours) than for those admitted (6.2 hours; IQR 4.7 to 8.9 hours), with a difference of 0.8 hours (95% confidence interval 0.3 to 1.3 hours). The difference disappeared when we excluded the 277 patients who had received a diagnostic CT pulmonary angiography or ventilation-perfusion scan before ED arrival. Among this modified cohort, ED median length of stay for patients directly discharged home (6.0 hours; IQR 4.6 to 7.2 hours) was similar to that of those admitted (6.4 hours; IQR 5.0 to 9.0 hours; difference 0.4 hours; 95% confidence interval -0.3 to 1.9 hours). Emergency physicians often consulted a specialist before sending home patients with acute pulmonary embolism (Table 4) .
Thirteen pulmonary embolism patients (7.2%) who had been discharged home had a 5-day pulmonary embolismrelated return visit, 5 of whom (2.8%) required a short hospitalization (range 1 to 5 nights). The complaints and diagnoses of the hospitalized patients are described briefly in Table E5 , available online at http://www.annemergmed. com.
We report 30-day adverse events in Table 5 . All-cause mortality was significantly lower among patients who were discharged home compared with those hospitalized. Two patients died within 30 days after outpatient management; both were discharged home with hospice consultations for expected near-term death, one from metastatic pulmonary adenocarcinoma and the other from severe dementia.
The interrater reliability kappa values for the 9 nondemographic variables of the Pulmonary Embolism Severity Index ranged from 0.85 to 1.00. The weighted kappa for the risk class was 0.99. The kappa values for the 5-day outcomes were not available because there were no events among these 68 cases. The percentage agreement for each of the variables ranged from 98.5% to 100% (median 100%; IQR 98.5% to 100%).
LIMITATIONS
This study is subject to the limitations inherent in retrospective cohort studies, although we tried to temper these by following recommended principles for chart review studies. 39, 40 Some of those shortcomings are mitigated by our comprehensive electronic health record, our ability to capture outcomes outside the health care system, and the study's high interrater reliability. We were unable to blind the abstractors to this study's hypotheses, although these were not stated explicitly until after the completion of data collection. We did not include socioeconomic variables, nor did we correlate real-time department census and treating physician workload with disposition decisions, although these may well be associated. 41 A few physicians involved in the eSPEED study may have worked some shifts at non-eSPEED study EDs, which may have increased home discharge in these EDs during the last 8 months of the 28-month study period (see the Figure) . We were unable to adjust for correlations of outcomes at the provider level, but noted no change in home discharge in non-eSPEED EDs during the eSPEED intervention period. 31 Also, we did not include interaction terms in the regression model.
We included patients with "presumed" pulmonary embolism, as randomized trials and large pulmonary embolism registries have done. 3, 12, 17, 28 The large multinational RIETE registry considers pulmonary embolism "objectively confirmed" in patients with inconclusive ventilation-perfusion scan results or negative CT scan results who also had lower limb venous compression ultrasonography positive for proximal deep venous thrombosis. 29 Such an approach to pulmonary embolism diagnosis has been shown to have a high specificity (99%). 42 Warfarin was the oral anticoagulant of choice for the treatment of acute pulmonary embolism during the study period. It has since been replaced by direct oral anticoagulants as the drug of choice for most patients with pulmonary embolism. 5 The effect these newer agents have on ED disposition decisions has not yet been fully evaluated, but early research suggests that availability of direct oral anticoagulants alone, apart from changes in structural processes of care, has little effect on pulmonary embolism site-of-care decisionmaking. 19, 43 Our patients received close follow-up after home discharge, a service that might not be readily available elsewhere. 26 The results we found reflect the study population and setting and may not be generalizable to other locations and different practice settings.
DISCUSSION
This retrospective cohort study of ED patients with acute pulmonary embolism describes the unscripted site-ofcare treatment patterns of physicians in 21 community EDs in a United States integrated health care delivery system. Collectively, approximately 1 in 13 patients was safely discharged home directly from the ED. Home discharge in our study varied considerably between facilities, despite the shared infrastructure. We were unable to identify facilityspecific predictors of home discharge. Even when one This variable includes patients with at least one measurement less than 90 mm Hg; only 34 of these (1.4%) had 2 or more systolic blood pressure levels less than 90 mm Hg at least 15 minutes apart, meeting formal diagnostic criteria for massive pulmonary embolism. ‡ Altered mental status as defined by the Pulmonary Embolism Severity Index includes disorientation, lethargy, stupor, and coma (see Table E1 , available online at http:// www.annemergmed.com). emergency medicine group serviced 2 different medical centers, similar percentages of home discharge did not prevail across these dyads, suggesting unidentified facilitylevel factors at play (Table 1) . This has been observed in studies of ED home discharge for other medical conditions. A large retrospective study of ED patients with atrial fibrillation across 154 hospitals in Ontario, Canada, found admission ranging widely, from 3.0% to 91.0%. 44 Compared with their admitted counterparts, patients with acute pulmonary embolism who were selected for outpatient management were more likely to be men, to be younger, to have arrived by private automobile, and had fewer abnormal vital signs and a lower percentage of syncope or presyncope. They also had a lower prevalence of cancer and concurrent deep venous thrombosis, more distal pulmonary embolism, and fewer elevated cardiac biomarker levels. These patient characteristics have intuitive appeal as predictors of favorable outcomes, and several are included in validated prognostic instruments. 11, 16, 45 Pulmonary embolism localization on CT pulmonary angiography is not included in these prognostic instruments. 11, 16, 45 Recent data from the large RIETE study found no correlation between central location of pulmonary embolism (ie, in the main pulmonary artery) and mortality among normotensive patients. 46 Other studies agree: incorporating clot burden into existing decision aids would not add predictive value. 47 We found that clot location, however, was independently predictive of initial site of care, even when controlling for vital sign abnormalities and elevation of biomarker levels (Tables 3  and E4 , available online at http://www.annemergmed. com). Comparison with the literature is difficult because most studies of outpatient pulmonary embolism management fail to report anatomic location of emboli and fail to correlate clot location with site-of-care management decisions.
Ours is one of the few outpatient studies to report the incidence of short-term pulmonary embolism-related return visits. This level of detail provides a more comprehensive picture of postdischarge care. Had we not found a low rate of 5-day pulmonary embolism-related return visits, we would suspect problems with patient selection, problems with patient discharge education or instructions, or difficulty securing timely postdischarge follow-up.
The low rate of 5-and 30-day adverse events we observed in the outpatient cohort suggests that emergency physicians and their consultants can identify patients eligible for safe and effective ambulatory management. These reassuring outcomes were noted even though some emboli are those that were reported as "segmental or lobar" and more distal (see Table E2 , available online at http://www.annemergmed.com). patients in the outpatient cohort had higher-risk attributes.
For example, at least 10% of patients discharged home had a history of cancer; had tachypnea (respiratory rate 24 to 30 breaths/min), tachycardia (pulse 100 to 110 beats/min), or low oxygen saturation (90% to 94%) at some point in their out-of-hospital or ED stay; or had a pulmonary embolism in the main pulmonary artery. Approximately one third of our cohort were categorized as higher risk by the Pulmonary Embolism Severity Index (classes III to V), a proportion similar to that of ED patients with acute pulmonary embolism who were safely discharged home from Ottawa Hospital. 48 As we have shown elsewhere, a patient's estimated 30-day all-cause mortality is an important variable in the initial site-of-care calculus, but it is not the only variable that influences the disposition decision. 32 There are multiple psychosocial, comorbid, and pulmonary embolismrelated factors to consider. 1, 32 Patients in a low-mortality class might have relative contraindications for home management, whereas those in a higher-risk mortality class may have minimal physiologic insult despite advanced age or chronic illness and may be suitable for home care. 5 Home discharge of ED patients with acute pulmonary embolism in the United States ranges from 0% to 25%, 18, 19, 31, 43, 49 lower than reports from London, the Netherlands, and Canada (28% to 55%). [11] [12] [13] [14] [15] The disparity is highlighted by the similarity in patient characteristics across these studies. These disparate site-of-care decisions suggest that most United States physicians may not be considering outpatient management for eligible patients who could safely avoid the costs and inconveniences of hospitalization. Although physicians in our study were specific in their patient selection (those chosen for home care were appropriate candidates), their selection nevertheless was insensitive (many not chosen were also good candidates according to validated risk scores).
In our study, more than one third of hospitalized patients were categorized as classes I to II on the Pulmonary Embolism Severity Index. In a validation study of the performance of the Index in the MAPLE cohort, we found the 30-day all-cause mortality of these low-risk patients (classes I to II) to be 0.3% (95% confidence interval 0.1% to 0.8%). 27 Many of these low-risk, low-mortality patients may have been appropriate candidates for outpatient treatment. If even half of these patients were free of relative contraindications to outpatient management 32 (a conservative estimate based on a large multinational randomized trial of patients with explicit Pulmonary Embolism Severity Index classification), 3 our percentages of home discharge would have increased from 7.5% to 19.5%, more consistent with those of United States medical centers that have implemented outpatient care pathways. 43, 49 Ottawa Hospital in Ontario, Canada, has achieved its distinctive pattern of care (55% safely discharged home) by adopting an "opt-out" paradigm: patients with acute pulmonary embolism are slated for outpatient care unless reasons can be found that they require hospitalization. 13 This approach is similar to that embodied in the Hestia criteria for outpatient management of adults with acute pulmonary embolism. 11 The default is that patients are going home from the ED, unless one of the exclusion criteria disqualifies them from outpatient management. When applied prospectively in 12 academic medical centers in the Netherlands, the Hestia criteria allowed direct outpatient management of 28% of their cohort and discharge home after a short hospital stay (<24 hours) in another 23%, all with reassuring short-term outcomes. Patients who were briefly admitted could have avoided the overnight hospitalization had the needed imaging studies been available around the clock.
Reducing unnecessary hospitalization will require physician education, but education alone may be insufficient to overcome the inertia of entrenched practice patterns. 50, 51 The ease of use of direct oral anticoagulants, especially those that do not require initial therapy with injectable agents, may facilitate outpatient management, 52 but some research suggests otherwise. 19 The failure of the newer agents to transform care delivery may be due to their unfamiliarity to physicians, lack of reversal agents, or concerns about increased patient costs. 43 EDs that have demonstrated increased rates of safe home discharge often have systems in place both to help physicians identify patients who are eligible for outpatient management and to ensure close follow-up for those discharged home. 11, 13, 31, 43, 49 More EDs, medical centers, and health care delivery systems are likely to follow suit as evidence continues to mount that carefully selected ED patients with acute pulmonary embolism can safely forgo the risks and costs of hospitalization.
In conclusion, we found that outpatient management for ED patients with acute pulmonary embolism was relatively uncommon and quite variable across 21 medical centers in a United States integrated health care delivery system. A low incidence of adverse outcomes suggests appropriate patient selection, although opportunities exist to expand outpatient care to a greater pool of eligible patients. Emboli that were lobar, main, or saddle were categorized as "proximal" and sum to 1,152 (52.8% of 2,180). Those that were "lobar or segmental," segmental, or subsegmental were categorized as "distal" and sum to 996 (45.7%). *Location determined by a study radiologist's interpretation of the original radiologist's report. The study radiologist was blind to the patients' clinical characteristics and outcomes. † Of the 156 subsegmental emboli, 104 were described as single (4.8% of 2,180) and 52 as multiple. 
